Investigational Site Number 3207

Nizhny Novgorod 603076

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis — Completed